Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-05-01

Clinical Trial Update: Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism [Phase 4]

View source ↗

Summary

This clinical trial update discusses how ACTH stimulation with Synacthen infusion may influence the results of adrenal venous sampling in a patient with primary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Synacthen (tetracosactide)

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Primary Aldosteronism | Phase 4 | Status: UNKNOWN